Recombinant CCL2 (Carlumab Biosimilar) 抗体
Quick Overview for Recombinant CCL2 (Carlumab Biosimilar) 抗体 (ABIN7490987)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
- 
    - 
                                            原理
- Anti-CCL2 (carlumab biosimilar) mAb
- 
                                            产品特性
- CNTO 888
- 
                                            纯化方法
- Purified from cell culture supernatant by affinity chromatography
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- ELISA 1:5000-10000, Flow Cyt 1:100
- 
                                            说明
- 
                        Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            溶解方式
- Reconstitute with deionized water
- 
                                            缓冲液
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - CCL2 (Carlumab Biosimilar)
- 
                                            物质类
- Biosimilar
- 
                                            背景
- Synonyms: HC11, MCAF, MCP-1
- 
                                            UniProt
- P13500
 抗原
- 
                    
 
                                     
                                     
                                    